Have a feature idea you'd love to see implemented?
Let us know!
AGEN Agenus Inc
Price (delayed)
$2.83
Market cap
$66.39M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$11.04
Enterprise value
$92.6M
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the
Highlights
The gross profit has soared by 77% YoY
Agenus's revenue has soared by 59% YoY
AGEN's equity has shrunk by 126% YoY and by 21% QoQ
The quick ratio has plunged by 69% YoY and by 51% from the previous quarter
Key stats
What are the main financial stats of AGEN
Market
Valuations
Earnings
Shares outstanding
23.46M
Market cap
$66.39M
Enterprise value
$92.6M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.38
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.58
Revenue
$160.43M
Gross profit
$159.8M
Net income
-$227.64M
EBIT
-$86.52M
EBITDA
-$71.24M
Free cash flow
-$167.75M
Per share
Balance sheet
Liquidity
EPS
-$11.04
EPS diluted
-$11.04
Free cash flow per share
-$7.78
Book value per share
-$13.55
Revenue per share
$7.44
TBVPS
$9.74
Total assets
$238.48M
Total liabilities
$510.29M
Debt
$70.99M
Equity
-$292.34M
Working capital
-$220.49M
Debt to equity
-0.24
Current ratio
0.19
Quick ratio
0.17
Net debt/EBITDA
-0.37
Margins
Efficiency
Dividend
EBITDA margin
-44.4%
Gross margin
99.6%
Net margin
-141.9%
Operating margin
-62.8%
Return on assets
-82.8%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
-53.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AGEN stock price
How has the Agenus stock price performed over time
Intraday
2.54%
1 week
-7.21%
1 month
5.99%
1 year
-81.21%
YTD
-82.91%
QTD
-48.36%
Financial performance
How have Agenus's revenue and profit performed over time
Revenue
$160.43M
Gross profit
$159.8M
Operating income
-$100.8M
Net income
-$227.64M
Gross margin
99.6%
Net margin
-141.9%
The gross profit has soared by 77% YoY
AGEN's operating margin has soared by 70% YoY and by 12% from the previous quarter
Agenus's revenue has soared by 59% YoY
AGEN's operating income has surged by 53% year-on-year and by 11% since the previous quarter
Growth
What is Agenus's growth rate over time
Valuation
What is Agenus stock price valuation
P/E
N/A
P/B
N/A
P/S
0.38
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.58
The EPS is up by 32% year-on-year
AGEN's equity has shrunk by 126% YoY and by 21% QoQ
The stock's price to sales (P/S) is 92% less than its 5-year quarterly average of 4.9 and 76% less than its last 4 quarters average of 1.6
Agenus's revenue has soared by 59% YoY
Efficiency
How efficient is Agenus business performance
The return on sales has surged by 73% year-on-year and by 13% since the previous quarter
Agenus's return on assets has decreased by 18% YoY and by 11% QoQ
Dividends
What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AGEN.
Financial health
How did Agenus financials performed over time
AGEN's total assets is 53% lower than its total liabilities
Agenus's current ratio has shrunk by 70% YoY and by 49% QoQ
The quick ratio has plunged by 69% YoY and by 51% from the previous quarter
Agenus's debt is 124% higher than its equity
AGEN's equity has shrunk by 126% YoY and by 21% QoQ
The debt to equity has surged by 61% year-on-year and by 20% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.